Open AccessTETRAPLEGIA IN A PATIENT- AN UNCOMMON POST COVID-19VACCINATION ADVERSE EVENT: A CASE REPORT
Author(s) -
Ferguson Ayemere Ehimen,
Iboro Samuel Akpan,
Victor Onyeka Nwanna,
Robert O. Iyamu,
Morgan Ikponmwosa
Publication year - 2021
Publication title -
international journal of advanced research
Language(s) - English
Resource type - Journals
ISSN - 2320-5407
DOI - 10.21474/ijar01/13184
Subject(s) - tetraplegia , medicine , vaccination , adverse effect , weakness , covid-19 , intensive care medicine , transverse myelitis , pharmacovigilance , pediatrics , spinal cord injury , surgery , immunology , spinal cord , disease , psychiatry , infectious disease (medical specialty)
COVID-19 vaccination is an effective method for reducing COVID-19 infection rates. Several clinical publications, however, have linked the use of this vaccination to a variety of untoward events.Here we present the case of an 18-year-old adult who developed tetraplegia or quadriplegia, a day after taking the first dose of his Astra-Zeneca COVID-19 Vaccine, despite the absence of any other known triggers or predisposing factors. This finding suggests a link between the Astra-Zeneca COVID-19 vaccine and quadriplegia/Acute transverse myelitis.Adults who experience any sort of paresthesia or minor weakness in their limbs after receiving COVD-19 vaccine should seek medical attention right away, and health care providers should be on the lookout for indicators of paralysis.Sufficient evidence is needed to better understand the potential link between COVID-19 immunizations and quadriplegia, and if one is found, the risk must be weighed against the millions of people who have been safely vaccinated, as well as the known morbidity and death associated with COVID-19 infection.As vaccines become more widely available, its critical that all potential adverse reactions be reported so that we can keep an eye out for relatively uncommon but potentially dangerous side effects that were not found in vaccine studies.